Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts

Cancer Letters

Volumn 215, Issue 1, 2004, Pages 53-59

  Carnesecchi, Stephanie ^a   Bras Gonçalves, Rui ^b   Bradaia, Amyaouch ^c   Zeisel, Mirjam ^a   Gossé, Francine ^a   Poupon, Marie France ^b   Raul, Francis ^a  

^a INSERM   (France)

^b INSTITUT CURIE   (France)

^c CNRS   (France)

Author keywords

5 FU metabolism; Caco 2 cells; Monoterpene; TC 118 tumors; Xenografts

Indexed keywords

ESSENTIAL OIL; FLUOROURACIL; GERANIOL; THYMIDINE KINASE; THYMIDYLATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER TRANSPLANTATION; COLON CANCER; COLON TUMOR; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG EFFICACY; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; DNA; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HUMANS; MICE; MICE, NUDE; OILS, VOLATILE; PLANT OILS; RNA, MESSENGER; TERPENES; THYMIDINE KINASE; THYMIDYLATE SYNTHASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 4544364825     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.06.019     Document Type: Article

References (21)

1. C.C. Boring, T.S. Squires, T. Tong, and S. Montgomery Cancer statistics CA Cancer J. Clin. 44 1994 26 37
2. G.J. Peters, C.L. Van der Wilt, B. Van Triest, G. Codacci-Pisanelli, P.G. Johnston, C.J. Van Groeningen, and H.M. Pinedo Thymidylate synthase and drug resistance Eur. J. Cancer 31 1995 1299 1305
3. P.J. Ferguson, O. Collins, N.M. Dean, J. De Moor, C.S. Li, M.D. Vincent, and J. Koropatnick Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells Br. J. Pharmacol. 127 1999 1777 1786
4. D.R. Mans, I. Grivicich, G.J. Peters, and G. Schwartsmann Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines Eur. J. Cancer 35 1999 1851 1861
5. C. Yasuda, M. Kato, D. Kuroda, and H. Ohyanagi Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3′-azido-3′-deoxythymidine for the gastric cancer cell line MKN28 in vivo Jpn. J. Cancer Res. 88 1997 97 102
6. T. Inada, Y. Ogata, T. Kubota, M. Tomikawa, S. Yamamoto, and J. Andoh 5-fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer Anticancer Res. 20 2000 2457 2462
7. K.D. Holen, and L.B. Saltz New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer Lancet Oncol. 2 2001 290 297
8. A. De Gramont, C. Tournigand, C. Louve, T. Andre, J.L. Molitor, and E. Raymond Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer Rev. Med. Intern. 18 1997 769 775
9. S.M. Shoff, M. Grummer, M.B. Yatvin, and C.E. Elson Concentration- dependent increase of murine P388 and B16 population doubling time by the acyclic monoterpene geraniol Cancer Res. 51 1991 37 42
10. S.G. Yu, L.A. Hildebrandt, and C.E. Elson Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice J. Nutr. 125 1995 2763 2767
11. S. Carnesecchi, Y. Schneider, J. Ceraline, B. Duranton, F. Gosse, N. Seiler, and F. Raul Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells J. Pharmacol. Exp. Ther. 298 2001 197 200
12. S. Carnesecchi, K. Langley, F. Exinger, F. Gosse, and F. Raul Geraniol, a component of plant essential oils, sensitizes human colonic cancer cell to 5-fluorouracil treatment J. Pharmacol. Exp. Ther. 301 2002 625 630
13. R.A. Bras-Goncalves, M. Pocard, J.L. Formento, F. Poirson-Bichat, G. De Pinieux, and I. Pandrea Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis Gastroenterology 120 2001 874 888
14. P. Skehan, R. Storen, D. Scudiero, A. Monks, J. McMahon, D. Vistica, and J.T. Warren Nex colorimetric cytotoxic assay for anticancer-drug screening J. Natl Cancer Inst. 82 1990 1107 1112
15. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 1984 27 55
16. M.F. Poupon, F. Arvelo, A.F. Goguel, Y. Bourgeois, M. Jacrot, and N. Hanania Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates J. Natl Cancer Inst. 85 1993 2023 2029
17. S. Carnesecchi, A. Bradaia, B. Fischer, D. Coelho, M. Schöller-Guinard, F. Gosse, and F. Raul Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells J. Pharmacol. Exp. Ther. 303 2002 711 715
18. G.J. Peters, C.L. Van der Wilt, C.J. Van Moorsel, J.R. Kroep, A.M. Bergman, and S.P. Ackland Basis for effective combination cancer chemotherapy with antimetabolites Pharmacol. Ther. 87 2000 227 253
19. S. Copur, K. Aiba, J.C. Drake, C.J. Allegra, and E. Chu Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil Biochem. Pharmacol. 49 1995 1419 1426
20. C.T. Hsueh, D. Kelsen, and G.K. Schwartz UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner Clin. Cancer Res. 4 1998 2201 2206
21. K.A. Whartenby, J.W. Darnowski, S.M. Freeman, and P. Calabresi A role for MAP kinase in the antitumor activity of a nucleoside analog Cancer Gene Ther. 9 2002 37 43